SLDB
NASDAQ · Biotechnology
Solid Biosciences Inc
$9.08
+0.78 (+9.40%)
Open$8.23
Previous Close$8.30
Day High$9.12
Day Low$8.13
52W High$8.87
52W Low$3.79
Volume—
Avg Volume2.98M
Market Cap820.09M
P/E Ratio—
EPS$-1.95
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+20.0% upside
Current
$9.08
$9.08
Target
$10.90
$10.90
$9.47
$10.90 avg
$14.24
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 294.33M | 265.12M | 296.42M |
| Net Income | 32.12M | 33.11M | 29.81M |
| Profit Margin | 10.9% | 12.5% | 10.1% |
| EBITDA | 56.98M | 46.74M | 49.34M |
| Free Cash Flow | 40.15M | 38.44M | 35.75M |
| Rev Growth | +16.9% | -8.0% | -9.5% |
| Debt/Equity | 0.34 | 0.27 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |